RMBV (RMBV Private Equity), based in the Netherlands, plans to invest $100 million in the Egyptian market in 2025. This investment will focus on acquiring minority stakes in 4 to 5 companies, according to principal partner Ahmed Badr El-Din, in an interview with “Al Sharq.”
Badr El-Din explained that the new investments will be directed towards medium-sized companies operating in key sectors such as the food industry, medical tourism, and export-oriented businesses, as well as those involved in import substitution. He emphasized that the company’s strategy is centered on transforming small and medium-sized enterprises in North Africa into leading players in their respective industries.
RMBV’s portfolio already includes investments in several companies both in Egypt and abroad, such as Cleopatra Hospital Group, “Taaleem” (the owner of Nahda University), in addition to stakes in “Tawfiq Hospitals,” “Lilas” health products company in Tunisia, and “Cepro” in Algeria. The company’s strategy is focused on nurturing the growth of small and medium enterprises (SMEs) in the region, helping them grow into regional industry leaders.
“We are exploring various investment opportunities in Egypt across different sectors. Our investment policy focuses on acquiring stakes ranging between 20% and 40% in each company. Since our establishment in 2022, we have invested $200 million until the end of 2024,” Badr El-Din stated.
Previously, RMBV was part of the Dubai-based “Abraaj Group” before it transitioned to Badr El-Din and his team following the collapse of the UAE firm.
